Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis

Last 30 days: 73 accesses
Last 365 days: 862 accesses
All time: 3515 accesses

Désirée M van der Heijde^*, Dennis A Revicki, Katherine L Gooch, Robert L Wong, Hartmut Kupper, Neesha Harnam, Chris Thompson, Joachim Sieper and the ATLAS Study Group